Selected article for: "lmwh weight heparin and low molecular lmwh weight heparin treatment"

Author: Barma, P; Tazrean, S; Khalil, I
Title: D-Dimer May be a Prognostic Hematological Marker for COVID-19: A Retrospective Case Analysis.
  • Cord-id: 3v9wf2mz
  • Document date: 2021_10_1
  • ID: 3v9wf2mz
    Snippet: Cross linked fibrin as D-Dimer fragments formed by fibrinolysis and mainly detected in the blood sample. High D-Dimer level is associated with liver disease, malignancy, chronic kidney disease, cardio vascular disease, lung disease, pregnancy, inflammation and vacuities. The normal serum D-Dimer level considered upto 0.50mg/L in serological immunochromatography which is indicated to exclude the risk of thrombus formation related to life threatening deep vein thrombosis (DVT), disseminated intrav
    Document: Cross linked fibrin as D-Dimer fragments formed by fibrinolysis and mainly detected in the blood sample. High D-Dimer level is associated with liver disease, malignancy, chronic kidney disease, cardio vascular disease, lung disease, pregnancy, inflammation and vacuities. The normal serum D-Dimer level considered upto 0.50mg/L in serological immunochromatography which is indicated to exclude the risk of thrombus formation related to life threatening deep vein thrombosis (DVT), disseminated intravascular coagulation (DIC), pulmonary embolism (PE), and critical cardiovascular events. Anticoagulant therapy by Low molecular weight heparin (LMWH) is the choice of treatment. These case report represent increased D-Dimer might be considered as a strong biomarker to distinguish the moribund of COVID-19 positive patients in hospital.

    Search related documents:
    Co phrase search for related documents
    • Try single phrases listed below for: 1
    Co phrase search for related documents, hyperlinks ordered by date